[Asia Economy Reporter Hyungsoo Park] Ubicare is showing strong performance. As the number of confirmed cases of the novel coronavirus infection (COVID-19) increases, the usage rate of the untact (contactless) service "Ttokdak," which includes mobile hospital registration, appears to have influenced the stock price.
At 10:32 AM on the 2nd, Ubicare was trading at 4,560 KRW, up 7.42% from the previous day.
Sehoon Son, a researcher at NH Investment & Securities, stated, "Ttokdak, a service provided by the subsidiary Vibros, has been gradually increasing in usage due to COVID-19," and introduced, "The Ttokdak service is equipped with a mobile registration function linked to the EMR platform, which can reduce hospital waiting times."
He added, "Although Ttokdak was often applied to pediatrics due to the nature of the service, it is expected to expand to internal medicine, otorhinolaryngology, and other departments recently to minimize the time spent in hospitals and reduce secondary infections from the virus due to the COVID-19 outbreak."
Vibros recorded a net loss of 6.2 billion KRW last year. Researcher Son emphasized, "This year is considered the first year of popularizing Ttokdak, and business efforts are underway to stabilize the service," adding, "Next year, we plan to monetize through medical fee payments and real insurance claim services."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
